Organization Overview
Alternative names
fludeoxyglucose f-18 (2004)
acetaminophen (tylenol) (4 trials)
acetylsalicylic acid (aspirin) (8 trials)
adenosine (Adenocard) (1 trial)
armodafinil (nuvigil) (1 trial)
atazanavir (reyataz) (1 trial)
beclomethasone (vanceril) (3 trials)
bictegravir (Biktarvy) (2 trials)
bortezomib (velcade) (23 trials)
bupivacaine (Exparel) (1 trial)
bupropion (wellbutrin) (2 trials)
clopidogrel (plavix) (2 trials)
corticotropin (acthar) (3 trials)
dapagliflozin (farxiga) (2 trials)
daptomycin (cubicin) (1 trial)
desogestrel (Mercilon) (1 trial)
duloxetine (Cymbalta) (1 trial)
efavirenz (sustiva) (3 trials)
emtricitabine (emtriva) (5 trials)
enoxaparin (lovenox) (2 trials)
escitalopram (lexapro) (11 trials)
esomeprazole (nexium) (1 trial)
estradiol (progynon depot) (2 trials)
ethinyl estradiol (Estinyl) (2 trials)
fesoterodine (toviaz) (1 trial)
fondaparinux sodium (arixtra) (1 trial)
insulin degludec (tresiba) (1 trial)
insulin glargine (toujeo) (1 trial)
insulin human (humulin) (2 trials)
ketorolac (acuvail) (2 trials)
lactulose (cephulac) (2 trials)
ledipasvir (Harvoni) (1 trial)
leuprolide (lupron) (10 trials)
levobupivacaine (chirocaine) (5 trials)
metformin (glucophage) (3 trials)
metoclopramide (reglan) (1 trial)
metoprolol (lopressor) (2 trials)
micafungin (mycamine) (1 trial)
mirtazapine (remeron) (1 trial)
mycophenolate (myfortic) (8 trials)
naltrexone (revia) (22 trials)
nebivolol (bystolic) (1 trial)
nystatin (mycostatin) (1 trial)
olanzapine (zyprexa) (3 trials)
omeprazole (prilosec) (1 trial)
ondansetron (zofran) (2 trials)
patiromer (veltassa) (1 trial)
perampanel (fycompa) (1 trial)
pibrentasvir (Mavyret) (1 trial)
polyethylene glycol (3 trials)
posaconazole (noxafil) (1 trial)
potassium citrate (urocit-k) (1 trial)
propofol (diprivan) (6 trials)
propranolol (inderal) (1 trial)
quetiapine (seroquel) (2 trials)
recombinant human choriogonadotropin alfa (Ovidrel) (2 trials)
Rho(D) Immune Globulin Intravenous (Human) (WinRho) (1 trial)
ribavirin (virazole) (10 trials)
rifaximin (xifaxan) (3 trials)
rimabotulinumtoxinB (Myobloc) (4 trials)
risedronate (actonel) (2 trials)
risperidone (risperdal) (2 trials)
sargramostim (leukine) (91 trials)
sertraline (zoloft) (3 trials)
sildenafil (viagra) (7 trials)
sofosbuvir (sovaldi) (2 trials)
somatropin (protropin) (3 trials)
tacrolimus (prograf) (6 trials)
tenofovir alafenamide (genvoya) (3 trials)
treprostinil (remodulin) (1 trial)
triamcinolone (kenalog) (2 trials)
unfractionated heparin (1 trial)
valproic acid (depakene) (2 trials)
velpatasvir (Epclusa) (1 trial)
abiraterone (zytiga) (5 trials)
acetylcysteine (mucomyst) (7 trials)
allogeneic hematopoietic stem cells (Hemacord) (11 trials)
alteplase (Activase) (2 trials)
amiodarone (cordarone) (2 trials)
amphotericin b (fungizone) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (13 trials)
atorvastatin (lipitor) (2 trials)
autologous bone marrow (10 trials)
autologous mononuclear stem cell (5 trials)
bacampicillin (spectrobid) (1 trial)
bacille calmette-guerin (4 trials)
bevacizumab (avastin) (41 trials)
bicalutamide (casodex) (8 trials)
bleomycin (blenoxane) (6 trials)
calcitriol (rocaltrol) (4 trials)
carbenicillin (pyopen) (1 trial)
carboplatin (paraplatin) (48 trials)
carmustine (bicnu) (14 trials)
caspofungin (cancidas) (1 trial)
cetuximab (erbitux) (17 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (93 trials)
clarithromycin (biaxin) (9 trials)
clavulanate (Augmentin) (1 trial)
conjugated equine estrogens (1 trial)
COVID-19 convalescent plasma (2 trials)
cytarabine (cytosar-u) (36 trials)
dactinomycin (cosmegen) (4 trials)
daunorubicin (cerubidine) (9 trials)
degarelix acetate (firmagon) (5 trials)
dexmedetomidine (precedex) (3 trials)
docetaxel (taxotere) (38 trials)
doxorubicin (Doxil) (58 trials)
doxycycline (vibramycin) (3 trials)
enzalutamide (xtandi) (6 trials)
etoposide (vepesid) (54 trials)
filgrastim (neupogen) (14 trials)
floxuridine (fudr) (16 trials)
fludeoxyglucose f-18 (19 trials)
fluorouracil (efudex) (42 trials)
foscarnet (foscavir) (2 trials)
gabapentin (neurontin) (1 trial)
ganciclovir (cytovene) (2 trials)
gemcitabine (gemzar) (50 trials)
glycopyrronium (robinul) (1 trial)
goserelin (zoladex) (5 trials)
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (2 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (2 trials)
immune globulin (human) (3 trials)
indocyanine green (ic-green) (1 trial)
interferon alpha-2b (Intron-A) (16 trials)
in vitro-treated bone marrow (4 trials)
lenalidomide (revlimid) (29 trials)
mebendazole (vermox) (1 trial)
mercaptopurine (purinethol) (2 trials)
methylprednisolone (medrol) (5 trials)
mezlocillin (mezlin) (1 trial)
mitomycin (mutamycin) (2 trials)
mitoxantrone (novantrone) (5 trials)
neostigmine (bloxiverz) (1 trial)
olaparib (lynparza) (5 trials)
onabotulinumtoxinA (Botox) (2 trials)
oxaliplatin (eloxatin) (26 trials)
paclitaxel (taxol) (69 trials)
palivizumab (Synagis) (1 trial)
pasireotide (signifor) (3 trials)
pegaspargase (oncaspar) (2 trials)
pemetrexed (alimta) (9 trials)
polyvalent antigen-klh conjugate vaccine (1 trial)
porfimer (photofrin) (2 trials)
prednisone (meticorten) (30 trials)
procaine benzylpenicillin (novocaine) (3 trials)
progesterone (progestasert) (1 trial)
rituximab (rituxan) (48 trials)
roflumilast (daliresp) (1 trial)
sorafenib (nexavar) (16 trials)
sulfamethoxazole (gantanol) (1 trial)
tamoxifen (nolvadex) (3 trials)
temozolomide (temodar) (27 trials)
tetracaine (pontocaine) (1 trial)
tivozanib (Fotivda) (4 trials)
vancomycin (Vancocin) (3 trials)
vinblastine (velban) (10 trials)
68ga−psma−hbed−cc (3 trials)
7-hydroxystaurosporine (2 trials)
90y-epratuzumab tetraxetan (1 trial)
abaloparatide (tymlos) (1 trial)
abemaciclib (verzenio) (2 trials)
acalabrutinib (calquence) (2 trials)
adenoviral vector expressing hsv-tk (1 trial)
afatinib (gilotrif) (3 trials)
aflibercept (zaltrap) (5 trials)
aldesleukin (proleukin) (9 trials)
alemtuzumab (campath) (4 trials)
allogeneic epstein-barr virus specific cytotoxic t-lymphocytes (2 trials)
allogeneic natural killer cells (3 trials)
allogeneic stem cells (3 trials)
amlodipine (norvasc) (2 trials)
amonafide dihydrochloride (1 trial)
anastrozole (arimidex) (2 trials)
apalutamide (erleada) (3 trials)
arsenic trioxide (trisenox) (13 trials)
arzoxifene hydrochloride (2 trials)
asparaginase (elspar) (3 trials)
atezolizumab (tecentriq) (4 trials)
autologous ebv specific cytotoxic t lymphocytes (1 trial)
autologous genetically modified t cells, ny-eso-1c259 t (1 trial)
autologous hematopoietic cell (4 trials)
autologous lymphocytes (2 trials)
autologous umbilical cord blood (4 trials)
azacitidine (vidaza) (7 trials)
bcr-abl peptide vaccine (1 trial)
bendamustine (treanda) (5 trials)
bexarotene (targretin) (2 trials)
binimetinib (mektovi) (3 trials)
brentuximab vedotin (adcetris) (5 trials)
busulfan (myleran) (11 trials)
cabazitaxel (jevtana kit) (2 trials)
cabozantinib (cometriq) (3 trials)
capecitabine (xeloda) (15 trials)
celecoxib (celebrex) (7 trials)
clofarabine (clolar) (4 trials)
clonidine (catapres) (3 trials)
cmv-specific t-cells (3 trials)
cobimetinib (cotellic) (2 trials)
cyanocobalamin (berocca) (1 trial)
cyclosporine (sandimmune) (6 trials)
dabrafenib (tafinlar) (3 trials)
dacarbazine (dtic-dome) (6 trials)
daratumumab (darzalex) (3 trials)
darbepoetin alfa (aranesp) (1 trial)
dasatinib (sprycel) (7 trials)
decitabine (dacogen) (7 trials)
deferasirox (exjade) (1 trial)
deferiprone (ferriprox) (2 trials)
deferoxamine (desferal) (4 trials)
dexrazoxane (zinecard) (2 trials)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)
disaccharide tripeptide glycerol dipalmitoyl (1 trial)
dolutegravir (tivicay) (1 trial)
durvalumab (imfinzi) (14 trials)
eltrombopag (promacta) (4 trials)
encorafenib (braftovi) (1 trial)
epirubicin (ellence) (4 trials)
erlotinib (tarceva) (15 trials)
estramustine (emcyt) (3 trials)
etaracizumab (abegrin) (1 trial)
everolimus (zortress) (20 trials)
fludarabine (fludara) (23 trials)
ga-68-dota-toc (Ga-68-dota-toc) (2 trials)
gallium-68-dotatate (netspot) (1 trial)
gemtuzumab ozogamicin (mylotarg) (2 trials)
gene-modified tumor cell vaccine therapy (1 trial)
gp-100 peptide vaccine (1 trial)
haplo-identical cord blood (1 trial)
hemopoietic stem cell (3 trials)
hla-matched related donor bone marrow (1 trial)
human dehydrated amnion chorion allograft (1 trial)
human fecal microbiota (4 trials)
ibritumomab tiuxetan (zevalin) (2 trials)
ibrutinib (imbruvica) (7 trials)
icosapent ethyl (vascepa) (1 trial)
idarubicin (idamycin) (4 trials)
inactivated influenza vaccine (1 trial)
incomplete freund's adjuvant (3 trials)
indigotindisulfonate sodium (1 trial)
interferon gamma-1b (actimmune) (1 trial)
interleukin-22 igg2-fc (1 trial)
in vitro-treated peripheral blood stem cell (1 trial)
iobenguane sulfate i-131 (1 trial)
ipilimumab (yervoy) (18 trials)
irinotecan (Camptosar) (40 trials)
isavuconazonium (cresemba) (1 trial)
itraconazole (sporanox) (1 trial)
ixabepilone (ixempra) (9 trials)
ketoconazole (nizoral) (3 trials)
keyhole limpet hemocyanin (2 trials)
klh-linked gd2l and gd3l (1 trial)
labetalol (trandate) (1 trial)
lamivudine (epivir) (4 trials)
lenvatinib (lenvima) (1 trial)
lu177 monoclonal antibody j591 (2 trials)
lymphokine-activated killer cells (1 trial)
maitake mushroom extract (1 trial)
maraviroc (selzentry) (2 trials)
mechlorethamine (mustargen) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (33 trials)
methadone (methadose) (2 trials)
methyldopa (aldomet) (1 trial)
methylphenidate (ritalin) (2 trials)
midostaurin (rydapt) (1 trial)
minocycline (minocin) (3 trials)
mogamulizumab (poteligeo) (1 trial)
motexafin gadolinium (1 trial)
multi-valent pneumococcal conjugate vaccine (1 trial)
nifedipine (procardia) (1 trial)
nitazoxanide (alinia) (3 trials)
nivolumab (opdivo) (16 trials)
ny-eso-1 and melan-a/mart-1 peptides (1 trial)
ny-eso-1(c259)t cells (1 trial)
ofatumumab (arzerra) (1 trial)
osimertinib (tagrisso) (1 trial)
oxycodone (oxycontin) (1 trial)
palbociclib (ibrance) (8 trials)
palifermin (kepivance) (3 trials)
palonosetron (aloxi) (1 trial)
panitumumab (vectibix) (4 trials)
pazopanib (votrient) (3 trials)
pegylated arginine deiminase (5 trials)
pembrolizumab (keytruda) (12 trials)
pentostatin (nipent) (3 trials)
pertuzumab (perjeta) (5 trials)
pexidartinib (Turallo) (2 trials)
pioglitazone (actos) (2 trials)
plerixafor (mozobil) (4 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
polatuzumab vedotin (Polivy) (1 trial)
pralatrexate (folotyn) (4 trials)
procarbazine (matulane) (7 trials)
pyrimethamine (daraprim) (1 trial)
radium-223 (xofigo) (2 trials)
ramucirumab (cyramza) (2 trials)
regorafenib (stivarga) (2 trials)
ribociclib (kisqali) (1 trial)
rifapentine (priftin) (2 trials)
romidepsin (istodax) (6 trials)
romiplostim (nplate) (2 trials)
ruxolitinib (jakafi) (4 trials)
sitagliptin (januvia) (3 trials)
sodium phenylbutyrate (buphenyl) (1 trial)
talimogene laherparepvec (Imlygic) (1 trial)
t-cell depleted peripheral blood stem cells (1 trial)
telaprevir (incivek) (1 trial)
temsirolimus (torisel) (8 trials)
testosterone (delatestryl) (3 trials)
thalidomide (Thalomid) (16 trials)
tioguanine (Lanvis) (2 trials)
tocilizumab (actemra) (2 trials)
topotecan (hycamtin) (11 trials)
trabectedin (yondelis) (3 trials)
trametinib (mekinist) (5 trials)
trastuzumab (herceptin) (18 trials)
trastuzumab emtansine (kadcyla) (1 trial)
tretinoin (Retin-A) (6 trials)
trimetrexate (neutrexin) (3 trials)
triptorelin (Trelstar) (1 trial)
trivalent ganglioside vaccine (1 trial)
tumor-pulsed dendritic cells (2 trials)
valaciclovir (Valtrex) (1 trial)
vandetanib (caprelsa) (1 trial)
vemurafenib (zelboraf) (6 trials)
vinorelbine (navelbine) (7 trials)
vismodegib (erivedge) (1 trial)
vorinostat (zolinza) (9 trials)
124i-iodo-azomycin galacto-pyranoside (1 trial)
18f 4-l-fluoroglutamine (1 trial)
4h11-28z/fil-12/efgrt+ genetically-modified t cells (1 trial)
70-kd heat-shock protein (1 trial)
aluminum hydroxide (Gaviscon) (1 trial)
autologous cd34+ cells transduced with tns9.3.55 (1 trial)
capromab pendetide (Prostascint) (1 trial)
carboxyamidotriazole orotate (1 trial)
certolizumab pegol (cimzia) (1 trial)
crizotinib (xalkori) (1 trial)
ct7, mage-a3, and wt1 mrna-electroporated langerhans cells (1 trial)
dalfampridine (ampyra) (1 trial)
duvelisib (copiktra) (1 trial)
egfrt/19-28z/4-1bbl car t cells (2 trials)
engineered autologous t cells (1 trial)
erwinia asparaginase (Erwinaze) (1 trial)
exemestane (aromasin) (2 trials)
fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (1 trial)
ga-68labeled f(ab') 2- trastuzumab (1 trial)
globo-h-gm2-stn-tf-tn-klh conjugate (1 trial)
glycerol phenylbutyrate (ravicti) (1 trial)
haploidentical stem cell (1 trial)
human gp100 plasmid dna vaccine (1 trial)
human prostate-specific membrane antigen plasmid dna vaccine (1 trial)
icasp9m28z t cell infusions (1 trial)
idelalisib (zydelig) (1 trial)
idoxuridine (herplex) (1 trial)
in111 monoclonal antibody hu3s193 (1 trial)
klh conjugates of gd2l, gd3l, globo h, fucosyl gm1 (1 trial)
langerhans-type dendritic cells (1 trial)
mesothelin car t cells (1 trial)
monoclonal antibody f19 (1 trial)
monoclonal antibody muj591 (2 trials)
mouse gp100 plasmid dna vaccine (2 trials)
mouse prostate-specific membrane antigen plasmid dna vaccine (1 trial)
muc1-klh conjugate vaccine (1 trial)
muc1-klh vaccine/qs21 (3 trials)
muc-2-globo h-klh conjugate vaccine (3 trials)
n-propionylated polysialic acid (1 trial)
n-propionylated polysialic acid plus opt-821 adjuvant (1 trial)
polyglutamate camptothecin (1 trial)
sirolimus (rapamune) (2 trials)
sulfasalazine (azulfidine) (1 trial)
tf(c)-klh conjugate vaccine (1 trial)
thiopental (pentothal) (2 trials)
thomsen-friedenreich antigen (1 trial)
tigecycline (tygacil) (1 trial)
tositumomab (bexxar) (1 trial)
tucotuzumab celmoleukin (1 trial)
vaccine comprised of klh conjugates of gd2l, gd3l, globo h, fucosyl gm1, (1 trial)
venetoclax (venclexta) (1 trial)
vrc-hivmab080-00-ab (2 trials)
wst 11-mediated vtp therapy (1 trial)
wt1-sensitized allogeneic t-lymphocytes (1 trial)
wt1-sensitized t cells (1 trial)
xenogeneic tyrosinase dna vaccine (1 trial)
y90 conjugated chimeric g250 (1 trial)
y90 monoclonal antibody hu3s193 (3 trials)
alprostadil (prostin) (1 trial)
antihemophilic factor viii human (Hemofil M) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
cannabidiol (Epidiolex) (1 trial)
choline c11 (choline c-11) (4 trials)
dinoprostone (prostin e2) (1 trial)
eculizumab (Soliris) (1 trial)
elvitegravir (vitekta) (1 trial)
fibrinogen (human) (RiaSTAP) (1 trial)
Fluciclovine (Axumin) (2 trials)
fluconazole (diflucan) (1 trial)
gadopenteate dimeglumine (magnevist) (1 trial)
globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine (1 trial)